Multimodal data fusion for cancer biomarker discovery with deep learning

Area of Science:

• Biomedical data analysis
• Artificial intelligence in oncology
• Multimodal data integration

Background:

• Technological advances enable multi-scale analysis of high-dimensional patient data in oncology.
• Deep learning has improved biomedical data analysis, but often focuses on single data types.
• Integrating complementary data modalities is essential for understanding complex diseases like cancer.

Purpose of the Study:

• To highlight the importance of multimodal fusion approaches in oncology.
• To discuss challenges in integrating disparate biomedical data types.
• To explore deep learning opportunities for addressing data sparsity, interpretability, and standardization.

Main Methods:

• Review of current deep learning applications in multimodal biomedical data analysis.
• Identification of obstacles in data usability, clinical validation, and interpretation.
• Exploration of deep learning strategies for data fusion and interpretability.

Main Results:

• Single-modality approaches limit progress in personalized medicine.
• Multimodal fusion is critical for capturing disease heterogeneity and tailoring treatments.
• Significant obstacles remain in data standardization, interpretation, and validation.

Conclusions:

• Deep learning offers potential solutions for data scarcity and interpretability in multimodal oncology data.
• Addressing current challenges is vital for advancing personalized medicine through integrated biomedical data analysis.
• Further research is needed to develop robust multimodal fusion methods and clinical validation strategies.